amphetamine has been researched along with Cardiomyopathies in 8 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty patients admitted with heart failure and echocardiographic evidence of cardiomyopathy between 2005 and 2014 and who had a documented history of amphetamine abuse that was considered an important factor in the causation of their cardiomyopathy were retrospectively identified." | 5.22 | Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand. ( Bradley, J; Gabriel, RS; Kerr, AJ; Kueh, SA; Looi, JL; Lund, M; Sutton, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Berlot, B | 1 |
| Williams, MGL | 1 |
| Bucciarelli-Ducci, C | 1 |
| Kueh, SA | 1 |
| Gabriel, RS | 1 |
| Lund, M | 1 |
| Sutton, T | 1 |
| Bradley, J | 1 |
| Kerr, AJ | 1 |
| Looi, JL | 1 |
| Figueredo, VM | 1 |
| HALPERN, BN | 1 |
| MORARD, JC | 1 |
| DRUDI-BARACCO, C | 1 |
| O'Neill, ME | 1 |
| Arnolda, LF | 1 |
| Coles, DM | 1 |
| Nikolic, G | 1 |
| Ayres, PR | 1 |
| Call, TD | 1 |
| Hartneck, J | 1 |
| Dickinson, WA | 1 |
| Hartman, CW | 1 |
| Bartel, AG | 1 |
| Lam, D | 1 |
| Goldschlager, N | 1 |
2 reviews available for amphetamine and Cardiomyopathies
| Article | Year |
|---|---|
Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart.
Topics: Amphetamine; Anabolic Agents; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Chloroquine; | 2011 |
Myocardial injury associated with polysubstance abuse.
Topics: Adult; Amphetamine; Cardiomyopathies; Cocaine; Drug Synergism; Electrocardiography; Female; Heroin; | 1988 |
1 trial available for amphetamine and Cardiomyopathies
| Article | Year |
|---|---|
Clinical Characteristics and Outcomes of Patients with Amphetamine-Associated Cardiomyopathy in South Auckland, New Zealand.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cardiomyopathies; Female; Humans; Male; Middle Ag | 2016 |
5 other studies available for amphetamine and Cardiomyopathies
| Article | Year |
|---|---|
The colours of amphetamine-induced cardiomyopathy.
Topics: Administration, Inhalation; Adult; Amphetamine; Amphetamine-Related Disorders; Cardiomyopathies; Car | 2020 |
[Protective effect of reserpine on the lesions in acute myocardial degeneration induced by DL-amphetamine and the suppression of this action by monoamine oxidase inhibitors].
Topics: Amphetamine; Amphetamines; Behavior; Cardiomyopathies; Heart Diseases; Monoamine Oxidase Inhibitors; | 1962 |
Acute amphetamine cardiomyopathy in a drug addict.
Topics: Acute Disease; Adult; Amphetamine; Cardiomyopathies; Catheterization; Heroin; Humans; Male; Pulmonar | 1983 |
Amphetamine cardiomyopathy.
Topics: Adult; Amphetamine; Cardiomyopathies; Humans; Male; Substance-Related Disorders | 1983 |
Acute cardiomyopathy secondary to intravenous amphetamine abuse.
Topics: Adult; Amphetamine; Cardiomyopathies; Female; Humans; Pulmonary Edema; Substance-Related Disorders | 1982 |